Abstract:Background: Chronic pulmonary aspergillosis (CPA) is an underdiagnosed and misdiagnosed disease and now increasingly recognised. However, the diagnosis of CPA remains challenging. In this study, we aimed to investigate the diagnostic values of serum Aspergillus-specific IgG, IgA and IgM antibodies in patients with CPA. Methods: The prospective study was performed at Chinese People's Liberation Army General Hospital in Beijing, from January 2017 to December 2017. Adult patients with lung lesions presented as cavity, nodule, mass, bronchiectasis or severe fibrotic destruction with at least two lobes in CT imaging were enrolled. One hundred healthy persons were also enrolled as additional controls. The serum levels of Aspergillus-specific IgG, IgA and IgM antibodies and galactomannan (GM) levels were measured simultaneously by plate ELISA kit. Results: A total of 202 patients were enrolled in this study, including 42 CPA patients, 60 non-CPA patients and 100 healthy persons. The most common underlying lung diseases in CPA patients were bronchiectasis (28.6%) and COPD (19.0%). The most common symptoms in the CPA patients were cough (76.2%), sputum (71.4%), and fever (45.2%); chest pain (4.8%) was infrequent. Receiver operating characteristic (ROC) curve analysis revealed that the optimal CPA diagnostic cut-off of Aspergillus-specific IgG, IgA and IgM assays and GM test were 89.3 AU/mL, 8.2 U/mL, 73.3 AU/mL and 0.5μg/L, respectively. The serum levels of Aspergillus-specific IgG and IgA in CPA patients were higher than these in non-CPA patients or healthy persons. The sensitivities and specificities of Aspergillus-specific IgG, IgA, IgM tests and GM test were 78.6 and 94.4%, 64.3 and 89.4%, 50.0 and 53.7% and 71.4 and 58.1%, respectively. Conclusions: The sensitivity and specificity of serum Aspergillus-specific IgG assay are satisfactory for diagnosing CPA, while the performance of Aspergillus-specific IgA assay is moderate. Aspergillus-specific IgM assay and serum GM test have limited value for CPA diagnosis. Trial registration: NCT03027089 . Registered 20 January 2017.

Serum Dectin-1 in non-agranulocytic patients with pulmonary aspergillosis

[Serum Antigens Assay Combined with Chest CT Scan in Diagnosis of Invasive Pulmonary Aspergillosis].

1,25(OH)2D3 and VDR Signaling Pathways Regulate the Inhibition of Dectin-1 Caused by Cyclosporine A in Response to Aspergillus Fumigatus in Human Corneal Epithelial Cells.

Clinical Value Analysis of IgG Antibody Detection in Diagnosis of Chronic Pulmonary Aspergillosis

Up-regulation of Dectin-1 in Airway Epithelial Cells Promotes Mice Defense Against Invasive Pulmonary Aspergillosis.

Dectin-1 Mrna Expression in Lung of Different Immune Status Mice Infected with Aspergillus Fumigatus

Toll-like Receptor 2 and Dectin-1 Function As Promising Biomarker for Aspergillus Fumigatus Infection.

Negative (1,3)-Β-d-glucan and Elevated White Blood Cells Combined Procalcitonin Masquerading As Severe Pneumonia Eventually Diagnosed As Invasive Pulmonary Aspergillosis Proven by Bronchoalveolar Lavage Fluid Culture in a Diabetes Patient: a Case Report and Literature Review

Dectin-1 is inducible and plays a crucial role in Aspergillus -induced innate immune responses in human bronchial epithelial cells

The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.

Evaluation of a Commercial Quantitative Aspergillus Fumigatus-Specific IgM Assay for the Diagnosis of Invasive Pulmonary Aspergillosis.

The diagnostic value of detecting plasma 1,3-β-D-glucan for invasive fungal infections

Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis

Clinical significance of detection of D-lactate produced by bacteria in pulmonary in diagnosis of pulmonary bacterial infections

Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis

Clinical Analysis on Ninty-Six Cases of Secondary Aspergillosis in COPD Patients

Pentraxin 3 in Bronchoalveolar Lavage Fluid and Plasma in Non-Neutropenic Patients with Pulmonary Aspergillosis

The clinical value of Aspergillus -specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis

Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.

Diagnostic and Preventive Significance of Fungal Detection Combined with (1, 3) Β-D Glucan Detection for Pulmonary Fungal Infection

Serum Galactomannan Level for the Diagnosis of Invasive Pulmonary Aspergillosis in Hospitalized Patients with Chronic Obstructive Pulmonary Disease (COPD): Meta-analysis